Skip to main content

SILICON LABORATORIES INC.

For the period ended Oct 4, 2025. Filed Nov 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Oct 4, 2025 · Filed Nov 4, 2025

SLAB$221.61-0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets at and

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

October 4,2025December 28,2024
Assets
Current assets:
Cash and cash equivalents$341,403$281,607
Short-term investments97,622100,554
Accounts receivable, net67,30854,479
Inventories82,190105,639
Prepaid expenses and other current assets64,03659,754
Total current assets652,559602,033
Property and equipment, net128,323132,136
Goodwill376,389376,389
Other intangible assets, net25,42536,499
Other assets, net70,37175,617
Total assets$1,253,067$1,222,674
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$55,647$42,448
Deferred revenue and returns liability8,4473,073
Other current liabilities81,21652,362
Total current liabilities145,31097,883
Other non-current liabilities37,04444,770
Total liabilities182,354142,653
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued——
Common stock – $0.0001 par value; 250,000 shares authorized; 32,853 and 32,458 shares issued and outstanding at October 4, 2025 and December 28, 2024, respectively33
Additional paid-in capital130,97978,227
Retained earnings939,4981,001,721
Accumulated other comprehensive income23370
Total stockholders’ equity1,070,7131,080,021
Total liabilities and stockholders’ equity$1,253,067$1,222,674
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.